EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14: Shanghai, China Tuesday, March 25, 2025, 15:00 Hrs [IST] Everest Medicines, a biop ...

NEW YORK – Everest Medicines said on Sunday that the US Food and Drug Administration cleared an investigational new drug application (IND) seeking permission to begin studying its mRNA vaccine EVM14 ...

The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...

The FDA has cleared Everest Medicines’ Investigational New Drug (IND) application for EVM14, a Tumor-Associated Antigen (TAA) ...

The US Food and Drug Administration (FDA) has approved an investigational new drug (IND) application for Everest Medicines’ ...

Bernadeth Pons made a double-double performance to propel Creamline to its 17th straight semifinal appearance in the Premier ...

Everest Medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug ...

G2S2 Capital Inc. ("G2S2") announces that its wholly owned subsidiary has disposed of common shares ("Shares") of Knight ...

WORKPRO Tools, a trusted name in high-quality DIY tools, is proud to introduce its latest expansion to their catalog: The ...

SINGAPORE and NEW YORK, March 10, 2025 /PRNewswire/ -- SPRIM Global Investments ("SGI"), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, ...